
Sahar Javanmard
Examiner (ID: 7314, Phone: (571)270-3280 , Office: P/1627 )
| Most Active Art Unit | 1627 |
| Art Unit(s) | 1617, 1627, 1622 |
| Total Applications | 1231 |
| Issued Applications | 657 |
| Pending Applications | 113 |
| Abandoned Applications | 477 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19048528
[patent_doc_number] => 20240090497
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => SURFACTANT BLENDS FOR HYPOHALITE-BASED DISINFECTING COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/470859
[patent_app_country] => US
[patent_app_date] => 2023-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10475
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18470859
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/470859 | SURFACTANT BLENDS FOR HYPOHALITE-BASED DISINFECTING COMPOSITIONS | Sep 19, 2023 | Pending |
Array
(
[id] => 19262772
[patent_doc_number] => 20240206467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => Fipronil Containing Insecticide Gels
[patent_app_type] => utility
[patent_app_number] => 18/469951
[patent_app_country] => US
[patent_app_date] => 2023-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6374
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18469951
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/469951 | Fipronil containing insecticide gels | Sep 18, 2023 | Issued |
Array
(
[id] => 19083035
[patent_doc_number] => 20240109836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-04
[patent_title] => NON-HALLUCINOGENIC ARIADNE ANALOGS FOR TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/468258
[patent_app_country] => US
[patent_app_date] => 2023-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15199
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18468258
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/468258 | NON-HALLUCINOGENIC ARIADNE ANALOGS FOR TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS | Sep 14, 2023 | Pending |
Array
(
[id] => 18860137
[patent_doc_number] => 20230414571
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => APPLICATION OF SMALL-MOLECULE COMPOUND IN PREPARATION OF ANTITUMOR DRUG
[patent_app_type] => utility
[patent_app_number] => 18/466829
[patent_app_country] => US
[patent_app_date] => 2023-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7016
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18466829
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/466829 | APPLICATION OF SMALL-MOLECULE COMPOUND IN PREPARATION OF ANTITUMOR DRUG | Sep 13, 2023 | Pending |
Array
(
[id] => 19389359
[patent_doc_number] => 20240279229
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => METHODS OF TREATING OR PREVENTING A PROTEOPATHY
[patent_app_type] => utility
[patent_app_number] => 18/466051
[patent_app_country] => US
[patent_app_date] => 2023-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15319
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18466051
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/466051 | METHODS OF TREATING OR PREVENTING A PROTEOPATHY | Sep 12, 2023 | Pending |
Array
(
[id] => 19112700
[patent_doc_number] => 20240124450
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => Novel SIK Inhibitors
[patent_app_type] => utility
[patent_app_number] => 18/466034
[patent_app_country] => US
[patent_app_date] => 2023-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27598
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18466034
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/466034 | Novel SIK Inhibitors | Sep 12, 2023 | Pending |
Array
(
[id] => 19157643
[patent_doc_number] => 20240150350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => CXCR4 INHIBITORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/465823
[patent_app_country] => US
[patent_app_date] => 2023-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55706
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18465823
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/465823 | CXCR4 INHIBITORS AND USES THEREOF | Sep 11, 2023 | Pending |
Array
(
[id] => 19172434
[patent_doc_number] => 20240158408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-16
[patent_title] => Nitrogen-Containing Heterocyclic Compound, Pharmaceutical Compositions thereof and Use thereof
[patent_app_type] => utility
[patent_app_number] => 18/464607
[patent_app_country] => US
[patent_app_date] => 2023-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53635
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 585
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18464607
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/464607 | Nitrogen-Containing Heterocyclic Compound, Pharmaceutical Compositions thereof and Use thereof | Sep 10, 2023 | Pending |
Array
(
[id] => 18860201
[patent_doc_number] => 20230414635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => CONCOMITANT ADMINISTRATION OF GLUCOCORTICOID RECEPTOR MODULATORS AND CYP3A INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 18/241364
[patent_app_country] => US
[patent_app_date] => 2023-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40312
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18241364
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/241364 | Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors | Aug 31, 2023 | Issued |
Array
(
[id] => 19127169
[patent_doc_number] => 20240132522
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-25
[patent_title] => HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/458039
[patent_app_country] => US
[patent_app_date] => 2023-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27750
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18458039
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/458039 | HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF | Aug 28, 2023 | Pending |
Array
(
[id] => 19263523
[patent_doc_number] => 20240207220
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => CANNABIDIOL PREPARATIONS AND ITS USES
[patent_app_type] => utility
[patent_app_number] => 18/446405
[patent_app_country] => US
[patent_app_date] => 2023-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23205
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18446405
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/446405 | CANNABIDIOL PREPARATIONS AND ITS USES | Aug 7, 2023 | Pending |
Array
(
[id] => 20459370
[patent_doc_number] => 20260008793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-01-08
[patent_title] => IONIZABLE CATIONIC LIPIDS INCORPORATING SILICON
[patent_app_type] => utility
[patent_app_number] => 19/099450
[patent_app_country] => US
[patent_app_date] => 2023-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38507
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 1401
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19099450
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/099450 | IONIZABLE CATIONIC LIPIDS INCORPORATING SILICON | Jul 25, 2023 | Pending |
Array
(
[id] => 19248630
[patent_doc_number] => 20240199617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => HETEROAROMATIC NMDA RECEPTOR MODULATORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/221694
[patent_app_country] => US
[patent_app_date] => 2023-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6246
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18221694
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/221694 | HETEROAROMATIC NMDA RECEPTOR MODULATORS AND USES THEREOF | Jul 12, 2023 | Abandoned |
Array
(
[id] => 19691218
[patent_doc_number] => 20250009763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-09
[patent_title] => METHODS FOR EXTENDING LIFESPAN AND/OR DELAYING AGING
[patent_app_type] => utility
[patent_app_number] => 18/219105
[patent_app_country] => US
[patent_app_date] => 2023-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9979
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18219105
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/219105 | METHODS FOR EXTENDING LIFESPAN AND/OR DELAYING AGING | Jul 6, 2023 | Pending |
Array
(
[id] => 18877435
[patent_doc_number] => 20240000804
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => TREATMENT OF HEPATIC STEATOSIS RELATED OLIGO-OVULATION
[patent_app_type] => utility
[patent_app_number] => 18/343553
[patent_app_country] => US
[patent_app_date] => 2023-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12133
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18343553
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/343553 | TREATMENT OF HEPATIC STEATOSIS RELATED OLIGO-OVULATION | Jun 27, 2023 | Pending |
Array
(
[id] => 18921299
[patent_doc_number] => 20240024303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => Medical Treatments Based on Anamorelin
[patent_app_type] => utility
[patent_app_number] => 18/212720
[patent_app_country] => US
[patent_app_date] => 2023-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12871
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18212720
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/212720 | Medical Treatments Based on Anamorelin | Jun 21, 2023 | Pending |
Array
(
[id] => 19140400
[patent_doc_number] => 20240139181
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => METHODS FOR INDUCING PUPIL DILATION
[patent_app_type] => utility
[patent_app_number] => 18/203496
[patent_app_country] => US
[patent_app_date] => 2023-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10573
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18203496
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/203496 | METHODS FOR INDUCING PUPIL DILATION | May 29, 2023 | Pending |
Array
(
[id] => 18656090
[patent_doc_number] => 20230301961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => A19-144, A2-73 and Certain Anticholinesterase Inhibitor Compositions and Method for Anti-Seizure Therapy
[patent_app_type] => utility
[patent_app_number] => 18/320159
[patent_app_country] => US
[patent_app_date] => 2023-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4274
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18320159
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/320159 | A19-144, A2-73 and certain anticholinesterase inhibitor compositions and method for anti-seizure therapy | May 17, 2023 | Issued |
Array
(
[id] => 20770203
[patent_doc_number] => 12653855
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-06-16
[patent_title] => Optimizing volatile entourages in dry flowering plant mixtures
[patent_app_type] => utility
[patent_app_number] => 18/320001
[patent_app_country] => US
[patent_app_date] => 2023-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14844
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18320001
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/320001 | Optimizing volatile entourages in dry flowering plant mixtures | May 17, 2023 | Issued |
Array
(
[id] => 20686577
[patent_doc_number] => 12616705
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-05-05
[patent_title] => Use of cannabinoids in the treatment of Angelman syndrome
[patent_app_type] => utility
[patent_app_number] => 18/311221
[patent_app_country] => US
[patent_app_date] => 2023-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 0
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18311221
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/311221 | Use of cannabinoids in the treatment of Angelman syndrome | May 1, 2023 | Issued |